What to do: Do not consume, use, sell, serve, or distribute the recalled product
Audience: General public; Hotels, restaurants and institutions
Hazard classification: Class 3
Affected products
Brand
Product
Size
UPC
Codes
Intercity Packers Ltd.
Oyster N/Shell Royal Miyagi Ow
Variable
None
Harvest Date: 03/29/22 Process Date: 03/30/22 Harvest Location: BC Area 15-4 LF#: 0195337
Harvest Date: 04/04/22 Process Date: 04/06/22 Harvest Location: BC Area 15-4 LF#: 0195337
Issue
Intercity Packers Ltd. is recalling Intercity Packers Ltd. brand Oyster N/Shell Royal Miyagi Ow from the marketplace due to possible norovirus contamination.
The recalled product has been sold in British Columbia and Ontario and may have been distributed in other provinces and territories.
What you should do
If you think you became sick from consuming a recalled product, call your doctor
Check to see if you have the recalled product in your home or establishment
Do not consume the recalled product
Do not serve, use, sell, or distribute the recalled product
Recalled products should be thrown out or returned to the location where they were purchased
Consumers who are unsure if they have purchased the affected product are advised to contact their retailer
People with norovirus illness usually develop symptoms of gastroenteritis within 24 to 48 hours, but symptoms can start as early as 12 hours after exposure. The illness often begins suddenly. Even after having the illness, you can still become re-infected by norovirus. The main symptoms of norovirus illness are diarrhea, vomiting (children usually experience more vomiting than adults), nausea and stomach cramps. Other symptoms may include low-grade fever, headache, chills, muscle aches and fatigue (a general sense of tiredness). Most people feel better within one or two days, with symptoms resolving on their own, and experience no long-term health effects. As with any illness causing diarrhea or vomiting, people who are ill should drink plenty of liquids to replace lost body fluids and prevent dehydration. In severe cases, patients may need to be hospitalized and given fluids intravenously.
This recall was triggered by findings by the Canadian Food Inspection Agency during its investigation into a foodborne illness outbreak.
The Public Health Agency of Canada is investigating an outbreak of human illness. Please refer to the Public Health Notice for further details on this active outbreak investigation.
What is being done
The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.
The CFIA is verifying that industry is removing the recalled product from the marketplace.
Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46
For Subset of Patients Previously Receiving 3rd Generation EGFR-TKI: PFS Hazard Ratio of 0.48...
Vivacelle Bio, a late-stage biopharma company developing life-saving treatments for shock and trauma, today announced that Cuthbert Simpkins MD, FACS,...
On 24 May 2024, Bidco and K1 announced that the offer document (the "Offer Document") in relation to Bidco's offer to acquire the entire issued and to be issued share capital of MariaDB plc (the "Offer") had been...
Inocras Inc., a leader in whole genome sequencing (WGS) diagnostics and precision medicine, is proud to present groundbreaking research on radiogenomics and homologous recombination deficiency (HRD) in breast cancer at the American Society of...
Numinus Wellness Inc. ("Numinus" or the "Company") , a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is pleased to announce the...
SterlingBio, a leading US woman-owned Contract Research Organization (CRO), is thrilled to announce that it has secured exclusive global distribution rights for SureClinical's cutting-edge eClinical apps, platform, and cloud, including the management...